R.M. Rudd
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 7
- Occupational and environmental lung diseases 5
- Metastasis and carcinoma case studies 5
- Tracheal and airway disorders 4
- Oncology top 5%
- Lung Cancer Research Studies 11
- Infectious Diseases top 10%
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 5
- Otorhinolaryngology top 10%
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- N.H. GowerStephen SpiroRobert MilroyG. BothamleyDavid WallerMichael PeakeRichard StephensMahesh Parmar
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
R.M. Rudd
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Pulmonary and Respiratory Medicine 702
- Oncology 492
- Infectious Diseases 193
- Epidemiology 264
- Otorhinolaryngology 32
Countries citing papers authored by R.M. Rudd
This map shows the geographic impact of R.M. Rudd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M. Rudd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M. Rudd more than expected).
Fields of papers citing papers by R.M. Rudd
This network shows the impact of papers produced by R.M. Rudd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M. Rudd. The network helps show where R.M. Rudd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R.M. Rudd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Response to chemotherapy predicts longer survival in an individual patient meta-analysis of 1205 patients with mesothelioma | 2009 | 1 |
| 2 | 2005 | 15 | |
| 3 | 2004 | 293 | |
| 4 | 2004 | 2 | |
| 5 | The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting | 2002 | 43 |
| 6 | Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) | 2002 | 21 |
| 7 | A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer | 2002 | 3 |
| 8 | 1995 | 23 | |
| 9 | 1994 | 43 | |
| 10 | 1994 | 53 | |
| 11 | 1994 | 17 | |
| 12 | 1992 | 2 | |
| 13 | 1992 | 9 | |
| 14 | 1991 | 39 | |
| 15 | 1990 | 54 | |
| 16 | 1988 | 40 | |
| 17 | 1987 | 8 | |
| 18 | A practical guide to clinical oncology. 3. Tumors of the extremities, abdomen, and thorax | 1986 | 1 |
| 19 | A practical guide to clinical oncology. 4. Chemotherapy and immunotherapy | 1986 | 3 |
| 20 | 1983 | 5 |
About R.M. Rudd
R.M. Rudd is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer therapeutics and mechanisms (5 papers), Occupational and environmental lung diseases (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Metastasis and carcinoma case studies (5 papers) and Tracheal and airway disorders (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (702 citations), Oncology (492 citations) and Infectious Diseases (193 citations). R.M. Rudd has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include N.H. Gower, Stephen Spiro, Robert Milroy, G. Bothamley, David Waller, Michael Peake, Richard Stephens, Mahesh Parmar, Juraj Iványi and F. Festenstein. Their work appears in journals such as Journal of Clinical Oncology, Thorax, Lung Cancer, Occupational and Environmental Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.